PERSISTENT KINASE SIGNALS IN PC12 CELL DIFFERENTIATION
PERSISTENT KINASE SIGNALS IN PC12 CELL DIFFERENTIATION
批准号:
2186335
负责人:
LYNN E HEASLEY
金额:
$10.07万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1998-07-31
关键词:
PC12 cells SDS polyacrylamide gel electrophoresis biological signal transduction cell differentiation cell growth regulation enzyme activity enzyme substrate fibroblast growth factor growth factor receptors immunoprecipitation neurotrophic factors phosphorylation platelet derived growth factor protein tyrosine kinase receptor expression western blottings
中文摘要
这项提议的长期目标是定义具体的效应者
参与生长因子受体调控的酶和蛋白激酶
细胞分化和生长。作为模型系统的PC12
嗜铬细胞瘤细胞系对神经生长因子的可逆性反应
(NGF)和碱性成纤维细胞生长因子(BFGF)部分生长停滞
在G1和轴突延伸中,表皮生长因子(EGF)和
胰岛素样生长因子-I(IGF-I)不能诱导分化
取而代之的是,发挥适度的促分裂作用。所有这些增长因素
通过膜结合受体酪氨酸激酶传递信号。到目前为止,
区分NGF和NGF分化作用的特定信号
碱性成纤维细胞生长因子是由EGF和IGF-I的促有丝分裂作用产生的,目前仍不清楚。
本实验室的最新发现表明,p42/44有丝分裂原激活
蛋白(MAP)激酶持续激活和酪氨酸
被指导分化的生长因子磷酸化,而
有丝分裂原只能引起该通路的短暂激活。在此基础上
持续接触生长因子的发现和要求
保持分化的PC12细胞表型,这一提议将测试
假设特定效应酶的持续激活和
蛋白激酶区别于那些诱导
与那些在PC12细胞中发挥有丝分裂作用的细胞有区别。这个
该项目的具体目标是L)确定效应酶(GAP,
P13-K、PLC伽马等)诱导PC12细胞分化所必需的
使用缺乏激活一个或多个受体的能力的突变型人PDGF受体
更多的效应酶。β-PDGF受体是一种受体酪氨酸激酶
这在亲代PC12细胞中是不存在的,但导向可逆性轴突
生长、部分生长停滞和持续的MAPK激活
与NGF和bFGF稳定导入细胞时相似。这
允许一种分子遗传策略来剖析生长要素
因子受体信号转导参与PC12细胞分化。
该提案还寻求2)定义NGF、bFGF和
PDGF刺激p42/44 MAP持续磷酸化和激活
蛋白激酶在PC12细胞分化中的作用。重组p42 MAP激酶将被
用作蛋白激酶底物以鉴定和测定蛋白激酶
它会磷酸化并激活MAP的激酶。此外,p54的MAP激酶
和与p42/44相关的p34-cdc2蛋白激酶
将检查神经营养因子和神经营养因子的差异调节
有丝分裂原。最后,3)突变形式的p42蛋白激酶可能表现出
显性-阴性表型将在PC12细胞中表达,以确定
PC12生长因子信号转导中对p42/44 MAP激酶的需求
细胞分化。综合起来,这些目标将开始定义
转导受体的效应器和蛋白激酶网络
酪氨酸激酶刺激PC12细胞生长的信号
和差异化。
英文摘要
The long-term goal of this proposal is to define the specific effector
enzymes and protein kinases involved in growth factor receptor-regulated
cell differentiation and growth. As a model system the PC12
pheochromocytoma cell line reversibly responds to nerve growth factor
(NGF) and basic fibroblast growth factor (bFGF) with partial growth arrest
in G1 and neurite extension while epidermal growth factor (EGF) and
insulin-like growth factor-I (IGF-I) fail to induce differentiation and
instead, exert modest mitogenic actions. All of these growth factors
signal through membrane-bound receptor tyrosine kinases. To date, the
specific signals that distinguish the differentiation action of NGF and
bFGF from the mitogenic actions of EGF and IGF-I remain poorly defined.
Recent findings in this lab indicate that the p42/44 mitogen-activated
protein (MAP) kinases are persistently activated and tyrosine
phosphorylated by growth factors that direct differentiation while
mitogens cause only transient activation of the pathway. Based on this
finding and the requirement for constant growth factor exposure to
maintain the differentiated PC12 cell phenotype, this proposal will test
the hypothesis that persistent activation of specific effector enzymes and
protein kinases discriminates those growth factors that induce
differentiation from those that exert mitogenic actions in PC12 cells. The
specific aims of the project are to l) identify the effector enzymes (GAP,
P13-K, PLCgamma, etc.) required for induction of PC12 cell differentiation
using mutant human PDGF receptors that lack the ability to activate one or
more effector enzymes. The betaPDGF receptor is a receptor tyrosine kinase
that is absent in parental PC12 cells, but directs reversible neurite
outgrowth, partial growth arrest and persistent MAP kinase activation
similar to NGF and bFGF when stably transfected into the cells. This
permits a molecular genetic strategy to dissect the elements of growth
factor receptor signal transduction involved in PC12 cell differentiation.
This proposal also seeks to 2) define the mechanism by which NGF, bFGF and
PDGF stimulate persistent phosphorylation and activation of the p42/44 MAP
kinases in differentiating PC12 cells. Recombinant p42 MAP kinase will be
used as a protein kinase substrate to identify and assay protein kinases
that phosphorylate and activate the MAP kinases. Also, the p54 MAP kinase
and p34-cdc2 protein kinases which are related to the p42/44 MAP kinases
will be examined for differential regulation by neurotrophic factors and
mitogens. Finally, 3) mutated forms of p42 MAP kinase that may exhibit
dominant-negative phenotypes will be expressed in PC12 cells to ascertain
the requirement for p42/44 MAP kinases in growth factor signalling of PC12
cell differentiation. Together, these aims will begin to define the
network of effectors and protein kinases that transduce the receptor
tyrosine kinase-stimulated signals in PC12 cells resulting in cell growth
and differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colorado HNC SPORE Career Enhancement Program
-
批准号:10268849
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2021
-
负责人:LYNN E HEASLEY
-
依托单位:
Regulation of Targeted Therapeutic Response by the Immune Microenvironment in HNSCC
-
批准号:9974288
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:LYNN E HEASLEY
-
依托单位:
Regulation of Targeted Therapeutic Response by the Immune Microenvironment in HNSCC
-
批准号:10477265
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:LYNN E HEASLEY
-
依托单位:
Regulation of Targeted Therapeutic Response by the Immune Microenvironment in HNSCC
-
批准号:10266070
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:LYNN E HEASLEY
-
依托单位:
An FGFR1 oncogene driver pathway in head and neck cancer
-
批准号:9275384
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:LYNN E HEASLEY
-
依托单位:
An FGFR1 oncogene driver pathway in head and neck cancer
-
批准号:8544051
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:LYNN E HEASLEY
-
依托单位:
An FGFR1 oncogene driver pathway in head and neck cancer
-
批准号:8966650
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:LYNN E HEASLEY
-
依托单位:
An FGFR1 oncogene driver pathway in head and neck cancer
-
批准号:8814998
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:LYNN E HEASLEY
-
依托单位:
FGF-2 Autocrine Signaling in Lung Cancer
-
批准号:7760157
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
FGF-2 Autocrine Signaling in Lung Cancer
-
批准号:7370013
-
项目类别:
-
资助金额:$31.51万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
Role of JNK Pathway in Lung Tumorigenesis
-
批准号:7366994
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
FGF-2 Autocrine Signaling in Lung Cancer
-
批准号:8197119
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
Role of JNK Pathway in Lung Tumorigenesis
-
批准号:7537250
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
Role of JNK Pathway in Lung Tumorigenesis
-
批准号:7213542
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
Role of JNK Pathway in Lung Tumorigenesis
-
批准号:7754899
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
FGF-2 Autocrine Signaling in Lung Cancer
-
批准号:7534819
-
项目类别:
-
资助金额:$31.47万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
FGF-2 Autocrine Signaling in Lung Cancer
-
批准号:7993117
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
Role of JNK Pathway in Lung Tumorigenesis
-
批准号:7994853
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2007
-
负责人:LYNN E HEASLEY
-
依托单位:
Integrated MAP Kinase Signaling In Cell Differentiation
-
批准号:6332123
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2001
-
负责人:LYNN E HEASLEY
-
依托单位:
Integrated MAP Kinase Signaling In Cell Differentiation
-
批准号:6611338
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2001
-
负责人:LYNN E HEASLEY
-
依托单位: